Discovery and development of novel melanogenic drugs. Melanotan-I and -II.
Hadley
M E
ME
Department of Cell Biology and Anatomy, University of Arizona, Tucson 85724, USA.
Hruby
V J
VJ
Blanchard
J
J
Dorr
R T
RT
Levine
N
N
Dawson
B V
BV
al-Obeidi
F
F
Sawyer
T K
TK
D000595:Amino Acid Sequence; D000818:Animals; D016588:Anticarcinogenic Agents / Q000494:pharmacology*; D015195:Drug Design; D006801:Humans; D008969:Molecular Sequence Data; D010456:Peptides, Cyclic / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D013329:Structure-Activity Relationship; D000521:alpha-MSH / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use
D016588:Anticarcinogenic Agents; D010456:Peptides, Cyclic; C079282:melanotan-II; D000521:alpha-MSH; C027756:MSH, 4-Nle-7-Phe-alpha-